Michael
Trumpp
ab,
Anna
Oliveras
c,
Hannes
Gonschior
a,
Julia
Ast
d,
David J.
Hodson
de,
Petra
Knaus
b,
Martin
Lehmann
a,
Melissa
Birol
*c and
Johannes
Broichhagen
*a
aLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Str. 10, 13125 Berlin, Germany. E-mail: broichhagen@fmp-berlin.de
bFreie Universität Berlin, Institute of Chemistry and Biochemistry – Biochemistry, Thielallee 63, 14195 Berlin, Germany
cBerlin Institute of Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine, Hannoversche Str. 28, 10115 Berlin, Germany. E-mail: Melissa.Birol@mdc-berlin.de
dInstitute of Metabolism and Systems Research (IMSR), and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, UK
eOxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 7LE, UK
First published on 21st November 2022
Herein, we evaluate near-infrared ATTO700 as an acceptor in SNAP- and Halo-tag protein labelling for Förster Resonance Energy Transfer (FRET) by ensemble and single molecule measurements. Microscopy of cell surface proteins in live cells is perfomed including super-resolution stimulated emission by depletion (STED) nanoscopy.
We next explored the utility of ATTO700 for live-cell imaging. First, using the WST-1 assay we determined that, at the concentrations used, BG-ATTO700 and CA-ATTO700 do not affect HEK293 cell viability (Fig. S1, ESI†). Next, to check that ATTO700 is cell-impermeable, we transfected HEK293 cells with a construct6 (Fig. 3A) that places the SNAP-tag on the extracellular side of the plasmalemma due to an added transmembrane (TM) domain, while the Halo-tag resides in the intracellular space (SNAPf-TM-Halo). SNAPf-TM-Halo labelling resulted in only weak signals using either BG-ATTO700 or CA-ATTO700, which was unexpected for the extracellular SNAPf-tag (since in vitro labelling was successful, vide supra), but anticipated for the intracellular Halo-tag. Confirming expression, we labelled the construct with a second color, i.e. either permeable CA-JF549 or impermeable BG-Sulfo549 (Fig. S2A, ESI†), and confirmed sufficiently high expression levels. We then turned to the Halo-TM-SNAPf construct that presents the labelling tags the other way around across the plasma membrane. As expected, we did not observe any intracellular SNAPf-tag labelling, but clear and strong Halo-tag surface staining (Fig. 3B) with the respective ATTO700s. Again, expression levels were controlled with impermeable CA-Sulfo549 or permeable BG-JF549 (Fig. S2B, ESI†).
We next turned to the glucagon-like peptide-1 receptor (GLP1R), a class B G protein-coupled receptor (GPCR), involved in glucose-dependent insulin secretion. While GLP1R is well-characterized, there is still interest in its localization and trafficking, which might explain differences in responses to the various therapeutic ligands.13,14 Cell impermeable NIR dyes that preferentially label surface GLP1R are warranted for its investigation and biology applications. We therefore tested ATTO700 for its ability to label SNAP and Halo-tagged GLP1R. To this end, HEK293 cells were transfected with SNAP26m-GLP1R before labelling with BG-JF646 (Fig. 3C) or BG-ATTO700 (Fig. 3D). Employing confocal microscopy, we obtained clear images for cell surface labelling, and unlike the SNAPf-TM-Halo construct, SNAP26m-GLP1R was successfully ATTO700-labelled (cf.Fig. 3A vs. D).
We hypothesized that this puzzling behavior might arise from either: (1) proximity of the tags to the cell surface causing steric hindrance or repulsion from the negatively charged surface, or (2) the slightly different amino acid sequence of the tag. To test these hypotheses, we cloned a SNAP26m-TM-Halo construct (see ESI†) and reperformed the labelling experiment (Fig S2A, ESI†). Presence of only weak signals would demonstrate membrane proximity effects, while comparable labelling to SNAP26m-GLP1R would account for tag bias. Indeed, we detected similar signal intensities when comparing SNAPf-TM-Halo and SNAP26m-TM-Halo, supporting the role for steric hindrance and/or repulsion in signal loss. This observation is further supported by the distance of SNAP26m N-terminally fused to GLP1R, since the ectodomain of the GPCR separates the tag from the surface. Why is this not the case for Halo-TM-SNAP? Consulting crystal structures and exit channels of SNAP and Halo, the C-terminus is considerably closer to the cell membrane for SNAP (Fig. S3, ESI†). This requires the dye to get closer to the cellular surface to react covalently. Ultimately, this finding demonstrates the need to carefully validate different systems.
We next turned to STED super-resolution imaging to probe if ATTO700 is amenable to the high laser powers used to circumvent Abbe's Law, since a de-excitation beam at λ = 775 nm is used. In both cases, the diffraction limit was broken, and line scans with a full width at half maximum (FWHM) were obtained at ∼100 nm for membrane contact sites (Fig. 3D), with comparable performance to JF646 (Fig. 3C). Similar results were obtained when HEK293 cells were transfected with Halo-GLP1R followed by labelling with CA-JF646 (Fig. 3E) and CA-ATTO700 (Fig. 3F). While both dyes were STEDable, we noticed more pronounced intracellular labelling using JF646, while ATTO700 was restricted to the surface (cf.Fig. 3E and F), in our case a desirable trait for examination of surface GPCRs. We aimed to push the boundaries of STED imaging, by looking at SNAP- and Halo-tagged Tubb59 and claudin10a,15 where structures have constant diameters of 25 and 10 nm, respectively (Fig. S4, ESI†). Although signals were detected in post-fix labelled SNAP-Tubb5, Halo-Tubb5 and SNAP-claudin10a expressing COS7 cells, these were not amenable to STED nanoscopy due to their low signal intensities. Thus, while interrogation of intracellular targets remains limited with ATTO700, they could in the future be addressed if the phenoxazine-linked sulfonate is masked or erased to allow cell permeability (depending on the BG substrate).16 Nevertheless, these experiments demonstrate the applicability of ATTO700 to super-resolution imaging on the cell surface, with the dye comparing favorably to NIR fluorescent STEDable proteins such as SNIFP11 or iRFP680.17 It should be noted that super-resolution images of ATTO700 were acquired with 10–15% 775 nm STED power (cf. 40–60% for JF646) for efficient depletion. Therefore, ATTO700 is prone for less photobleaching as de-excitation powers usually outweigh excitation intensities by orders of magnitudes. To further characterize this, we recorded images with different depletion powers (Fig. 3G) and plotted against fluorescence intensity and FWHM to find the depletion efficiency (EffDepl (Halo:ATTO700) = 145.3 kW cm−2; EffDepl (SNAP:ATTO700) = 151.3 kW cm−2) (Fig. 3H) and saturation intensity (Isat (Halo:ATTO700) = 57.5 kW cm−2; Isat (SNAP:ATTO700) = 61.0 kW cm−2) (Fig. 3I), respectively. All values compare favorably to SBG-JF646 surface labelled SNAP-tags (EffDepl = 653.8 kW cm−2; Isat = 479.9 kW cm−2) (Fig. 3H, I and see also Fig. S5, ESI†), demonstrating the advantage of lower light intensities for deeper tissue imaging with less phototoxicity.
In summary, we have revisited the NIR dye ATTO700, finding that its photophysical performance is drastically enhanced when bound to SNAP- and Halo-tags, and demonstrate its applicability in single-molecule and super-resolution microscopy. Since fluorophores with spectral characteristics beyond 700 nm are scarce when compared to their green, red and far-red stablemates, we anticipate that ATTO700 will find more applications in molecular and cellular studies for surface exposed SNAP- and Halo-tagged proteins.
M. T. and J. B. performed chemical synthesis and characterization, protein labelling and ensemble measurements. A. O., M. B. and J. B. recorded single molecule spectroscopy. H. G. and M. L. performed STED nanoscopy. J. A., D. J. H. and P. K. provided reagents, protocols and resources. M. B. and J. B. conceived and supervised the study and wrote the manuscript with input from all authors. We thank Kilian Roßmann, Pascal Poc, Ramona Birke, Rozemarijn van der Veen for assistance, Kristin Kemnitz-Hassanin and Christian P. R. Hackenberger (all FMP) and Jana Roßius (BIMSB-MDC) for support.
P. K. was supported by DFG (SFB1444). This work was supported by the Sonnenfeld Foundation with a stipend to H. G. and a grant from the DFG to M. L. (GRK2318/TJ-Train A4). D. J. H. was supported by MRC (MR/N00275X/1 and MR/S025618/1) Project and Diabetes UK (17/0005681) Project Grants, as well as an ERC Frontier Research Guarantee Grant (EP/X026833/1). This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (Starting Grant 715884 to D. J. H.) and under the European Union's Horizon Europe Framework Programme (deuterON, Grant agreement no. 101042046 to J. B.). The research was funded by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC).
Footnote |
† Electronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d2cc04823j |
This journal is © The Royal Society of Chemistry 2022 |